A recent observational longitudinal study revealed that GSH was significantly reduced in the blood samples of COPD patients, moreover the expression of Nrf2 in PBMCs were significantly down-regulated in COPD patients at follow-up compared with non-COPD patients [57]. The gene discussed is NFE2L2; the disease is chronic obstructive pulmonary disease.